A major immunoregulatory mechanism in inflammatory infections and allergic dies Is the control of the balance of cytokines secreted by Thl/Th2 subsets of T helper (Th) cells. This might also be true in autoimmune diseas; a Th2 pattern that prevents an effective immune response in infections with intracellular bacteria may favor immunosuppression in autoimmune disease. The pattern of cytokine expression was compared in the synovial tissue from patients with a typical autoimmune disease, rheumatoid arthritis, and with a disorder with similar synovial pathology but driven by persisting exogenous antigen, reactive arthritis. We screened 12 rheumatoid and 9 reactive arthritis synovial tissues by PCR and in situ hybridization for their expression of T-cell cytokines. The cytokine pattern differs significantly between the two diseases; rheumatoid arthritis samples express a Thllike pattern whereas in reactive arthritis interferon y expression is accompanied by that of interleukin 4. Studying the expression of cytokines by in situ hybridization confimed the results found by PCR; they also show an extremely low frequency of cytokine-transcribing cells. In a double-staining experiment, it was demonstrated that interleukin 4 is made by CD4 cells. These experiments favor the possibility of therapeutic intervention in inflammatory rheumatic diseases by means of inhibitory cytokines.
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The control of the balance of cytokines secreted by differing T-cell subsets is emerging as a major immunoregulatory mechanism (1, 2) . The division ofT helper (Th) cells into Thl [secreting interferon y (IFN-y) and interleukin (IL) 2] and Th2 (secreting IL-4 and IL-5) found in the mouse (3) holds good for humans (2) , provided that attention is focused on IL-4 (4) . Cytokines of the Thl spectrum are generally elevated in successful responses to a variety of intracellular pathogens (5) , and Th2 cytokines are elevated in allergic diseases and in helminth infections (6, 7) . The balance appears to be maintained not only by the cytokines considered originally to be of Thl/Th2 type but also by other inhibitory cytokines such as transforming growth factor (3 and I1-10, which are not confined to one ofthe original subsets and can additionally be secreted by non-T cells (8, 9) . In this context the pattern of T-cell cytokines in reactive and rheumatoid arthritis is of particular interest. Not only is rheumatoid arthritis among the commonest of the candidate autoimmune diseases, it also offers easy access to the site of inflammation. Reactive and rheumatoid arthritis are sister diseases, in the sense that both are characterized by inflammation of joints and the development of similar synovial pathology. Reactive arthritis is triggered by intracellular bacteria that persist in the joint (10, 11) , whereas for rheumatoid arthritis, the triggering events are unknown but thought not to involve persistent infection. Comparison ofthe two diseases should be informative.
The importance of T cells in initiating and maintaining inflammation in the rheumatic diseases is still controversial.
Several groups have detected macrophage/monocyte cytokines in the inflamedjoint (12) , but it has been less easy to detect T-cell cytokines (13) . This has led to the suggestion that the pathogenesis ofarthritis is mediated solely by macrophages and their effector cytokines (14) , although the alternative view is that T-cell cytokines may be important but are expressed at levels too low for detection by conventional methods (13) .
To address this issue, the T-cell cytokine pattern of synovial membranes from patients with rheumatoid arthritis and reactive arthritis was examined by PCR and in most cases also by in situ hybridization, thus providing cross-validation of the two methods. Such methods offer the most sensitive available means, as exemplified by their success in detecting low level transcription in the thymus (15) . The main finding is of significantly differing cytokine patterns: in rheumatoid arthritis Thl but not Th2 cytokines were often found, whereas in reactive arthritis the Th2 cytokine 11-4 was often detected in addition to Thl cytokines.
MATERIALS AND METHODS
Patients. Twelve patients had active rheumatoid arthritis fulfilling at least four of the seven American College of Rheumatology (ACR) criteria, and 9 patients had reactive arthritis following infection with Chlamydia, Yersinia, Salmonella, Shigella, or Borrelia. Control biopsies from the gut of a patient suffering from Crohn disease and from an ulcerative colitis patient were also included. Synovial membrane was obtained by synovectomy (10 patients), diagnostic arthroscopy (4 patients), or needle biopsy ofthe knee joint (7 patients). Samples were placed in OCT medium (Miles) or normal saline for PCR analysis and snap-frozen in liquid nitrogen. As a control, peripheral blood lymphocytes (PBLs) from a healthy donor were stimulated with Con A (10 pg/ml) for 24 h, then diluted with nonstimulated PBLs, and subjected to RNA extraction or cytospun onto slides.
RNA Extraction and Reverse Transcription. Total cellular RNA was isolated from snap-frozen synovial membranes by using guanidinium thiocyanate buffer for disruption of the tissue followed by centrifugation through cesium chloride gradient (16 from either type of synovial membrane. However, the moresensitive method of hybridizing a radioactive probe to the PCR products did sometimes yield a band (Fig. 3) . By this test, 6 of 8 reactive arthritis samples but only 2 of the 10 tissues from rheumatoid patients were positive for IL-4. Likewise, IL-2 mRNA was detected in 1 of the 6 reactive arthritis and in 2 of the 10 rheumatoid samples, which were also negative when examined by normal PCR (Fig. 1) . Tissues from the two nonarthritic inflammatory diseases taken as controls are included in Fig. 2 (Fig. 1) . These cytokine-expressing cells were always present in clusters, as though responding to some local stimulus (Fig. 4) (22) , probably because of the stringent washing conditions. For two cytokines we were able to identify the cytokineproducing cells by their surface markers by combining immunohistology with in situ hybridization. As expected, the effector cytokine IL-1,3 was produced by CD68+ macrophages. IL-4 was produced by CD4+ lymphocytes in a reactive arthritis biopsy (Fig. 5) with no trend in cytokine production to be detected by PCR or by single-cell analysis (data not shown).
DISCUSSION
In this study, cytokine patterns were assessed in rheumatoid and reactive arthritis by PCR and in situ hybridization. T-cell cytokine mRNA was detected in the majority of samples, and previous failure to find it (12) was probably due to insensitive assays. Both methods gave satisfactorily concordant results. They provide information only of transcriptional activity (i.e., the presence of mRNA) and do not necessarily imply that cytokine protein is synthesized or secreted (23) . The detection of these cytokines at the inflammation site strengthens the case for T cells being responsible for inducing and maintining arthritis (13) , although monocytes and synovial lining cells and their products may nevertheless play the principal role in joint inflammation and tissue destruction (14) .
The major finding was a marked difference in the frequency of IL-4-positive samples between the two diseases, with a significantly higher number of reactive arthritis samples expressing discriminating between Thl and Th2 cells (17, 24) , and it behaved accordingly in the present study. There was no trend in cytokine pattern related to disease progression, although our data do not exclude that there is one that, early in these diseases, could be of great interest, particularly as possible key players in maintaining the disease states.
This study sets the two inflammatory arthritic diseases within a cytokine landscape hitherto populated mainly by infectious diseases and by atopy. Two leading examples are leishmaniasis (27) and leprosy (17) , where Thl cells exert a protective effect and sometimes also mediate hypersensitivity, subject in both cases to down-regulation by Th2 cells. Like reactive arthritis, these diseases are caused by intracellular pathogens protected against by Thl cytokines that activate macrophages. The reverse occurs in helminth infections (28) .
There is no previous work on cytokine balance in human autoimmune disease with which the present study can be compared. Animal models suggest that preferential activation of Thl responses is central to the pathogenesis of these diseases. Thus in experimental allergic encephalitis, a leading model of autoimmunity, IFN-y, IL-2, and tumor necrosis factor a are secreted at the peak of disease and IL-4 and transforming growth factor are secreted during recovery (29) . IL-4 probably participates in suppressing inflammation by down-regulating the macrophage-activating cytokine IFN-y (30) . In nonobese diabetic mice IFN-y production correlates with disease activity (31) , and treatment with anti-IFN-yantibody or IL-4 prevents onset of the disease (31, 32) . Rats can be rendered diabetic by manipulations favoring the Thl subset, and the otherwise doomed Thl-manipulated rat can be protected by the transfer of Th2 cells (33) .
Attempts to detect these antagonistic subsets in inflammatory arthritis in vivo have so far been unsuccessful (34 (34, 36) . No attempts to detect IL-5 or IL-10 in inflamed joint tissue have been reported. Only in rheumatoid arthritis serum and synovial fluid was an increase in IL-10 levels found (37) . In vitro T-cell cloning has been reported from rheumatoid arthritis synovial membrane (38) and from synovial fluid of reactive arthritis (39) (40) (41) ; this procedure, with its attendant bias, yields clones mainly of Thl type, with some production of .
The amount of cytokine mRNA was small, but so it is even in the infectious diseases where they are believed to play such an important role (2, 26) . This study suggests that past difficulties in detecting T-cell cytokines in inflammatory arthritis can be explained by the extremely low frequency of cytokine-expressing cells. At first sight the relevance ofthese few cells might seem doubtful. However, the production of these cytokines is probably restricted to the minority of T cells that have recently undergone antigenic stimulation, and there is increasing evidence that only a few such cells are needed to maintain an inflammatory lesion. Thus only 2% of T cells from tuberculoid leprosy skin lesions respond to the bacterial antigen (42) . In multiple sclerosis, the frequency of T cells responding to myelin-oligodendrocyte glycoprotein in the cerebrospinal fluid is 1:450 (43), and only 1:1000 T cells from synovial fluid in reactive arthritis respond to the bacterial antigen that triggered the disease (44) . Additionally, studies on the frequencies of cytokine-expressing cells have shown that only between 0.1 and 1% of all cells present in leprosy lesions express IFN-y (45). The frequencies observed here are thus in line with those reported previously for other forms of immunopathology.
The combined immunohistology/in situ hybridization experiment showed IL-4 secretion by CD4 T cells, but we have no information yet for IFN-y and IL-10. No doubt a more detailed identification of the cytokine-secreting cells is needed, although this is unlikely to change our view of the importance of these cytokines. After all, evidence is increasing that differentiation into Thl or Th2 cells is initiated by cytokines secreted by cells of the innate immune system (46) . Thus IFN-y is secreted by natural killer cells and promotes the development of the Thl subset and so does IL-12 expressed by macrophages (47) . The initial source of IL-4 expression, which induces the Th2 subset, is not known yet (46) . Therefore, even if the cytokines identified here are not themselves produced by T cells, they would nevertheless be expected to influence the differentiation of these cells.
IL-10 is expressed in both T-cell subsets and also by non-T cells in the inflammatory diseases leprosy and leishmaniasis (24, 26) . Regardless of the source of IL-10, like IL-4 (30), it probably contributes to the pathogenesis of arthritis by suppressing the bactericidal effector mechanisms of activated macrophages.
The association of rheumatoid arthritis with the major histocompatibility complex class II gene DR4 and of ReA with the major histocompatibility complex class I gene B27 cannot be explained by our data. However, recent evidence suggests that CD8 T cells may also divide functionally into two types, corresponding to Thl and Th2 CD4 cells (4, 48) .
In conclusion, T-cell cytokine transcription was detected in many synovial membranes from both rheumatoid and reactive arthritis patients. The frequency of cytokine-transcribing cells is extremely low, reflecting probably the low frequency of antigen-specific cells in the inflamedjoint tissue. In rheumatoid synovial membrane, these few cells display a strong bias toward the Thl cytokine pattern, with expression of IFN-y but not of IL4. On the other hand, in reactive arthritis the transcription of IFN-y and IL-2 is usually accompanied by that of IL-4. Under these different circumstances, both of these patterns can be regarded as detrimental, and a case can be made for their playing a causal role in both diseases, rather than merely reflecting disease activity. Could not rheumatoid arthritis resemble the Thl-manipulated rat, with cofactors such as HLA DR4, to account for the particular form of autoimmunity that emerges? As for reactive arthritis, the usual outcome of infection with Chlamydia or the other triggering organisms is cure, presumably reflecting the crucial role of Thl cells in combating intracellular infections (5) . A failure to mount this form of protective immune response, brought about by the inhibitory effect of IL4, could explain why only a minority of patients normally develop the disease in chronic form. If these arguments are accepted, they would strengthen the case for therapeutic intervention by means of inhibitory cytokines or anticytokine antibodies. As we come to learn more about the differentiation of Thl and Th2 cells in early and late stages of these inflammatory rheumatic diseases, it should become possible to design appropriate forms of intervention, including perhaps therapy by implantation of cytokine genes (49) . The present study contributes to that enterprise by focusing attention on IL4 as a candidate agent for intervention in rheumatoid arthritis, and on IFN-yor perhaps better (50) or anti-IL4 antibodies (27) for reactive arthritis. In a subject as difficult as this, the present data and their implications are unlikely to be accepted at all readily. Therapy will be the judge. Indeed the same may be said of the whole concept of cytokine balance: its importance will be judged by its ability to predict, formulate, and guide various forms of clinical intervention.
